These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7725511)

  • 1. Renal transplantation and dyslipidemia: characterization of a population and treatment with diet and low dose lovastatin.
    Downey P; Maiz A; Vaccarezza A; Pinto C; Retamal F; Martínez L
    Transplant Proc; 1995 Apr; 27(2):1803-5. PubMed ID: 7725511
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal lipoprotein (a) and lipid profiles in renal allograft recipients: effects of treatment with pravastatin.
    Lye WC; Hughes K; Leong SO; Tan CC; Lee EJ
    Transplant Proc; 1995 Feb; 27(1):977-8. PubMed ID: 7879252
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use and effect of simvastin in patients with type II diabetes].
    Camarda G
    Clin Ter; 1993 Aug; 143(2):105-7. PubMed ID: 8222540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic effect of a high-protein low-fat diet in transplant patients.
    Borges W; González Caraballo Z; Delpín EA; Morales Otero L
    Transplant Proc; 1996 Dec; 28(6):3400-1. PubMed ID: 8962328
    [No Abstract]   [Full Text] [Related]  

  • 6. HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.
    Castelao AM; Griñó JM; Andrés E; Gilvernet S; Serón D; Castiñeiras MJ; Roca M; Galcerán JM; González MT; Alsina J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1043-6. PubMed ID: 8442035
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statins (HMG-CoA reductase inhibitors), cholesterol and stroke].
    Marta-Moreno J; Echeandia C; Oliveros-Cid A; Figuerola A; Mola S
    Rev Neurol; 1998 Nov; 27(159):827-30. PubMed ID: 9859160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study].
    Romics L; Karádi I; Csanády M; Gógl A; Jánosi A; Ofner P; Tarján J; Varga L; Wórum F; Zeltner G
    Orv Hetil; 1994 Oct; 135(40):2187-91. PubMed ID: 7970631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
    Traindl O; Reading S; Franz M; Falger S; Klauser R; Gisinger J; Widhalm K; Kovarik J
    Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924
    [No Abstract]   [Full Text] [Related]  

  • 10. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

  • 12. Ubiquinone supplementation during lovastatin treatment: effect on LDL oxidation ex vivo.
    Palomäki A; Malminiemi K; Solakivi T; Malminiemi O
    J Lipid Res; 1998 Jul; 39(7):1430-7. PubMed ID: 9684746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low-fat diet supplemented with monounsaturated fat results in less HDL-C lowering than a very-low-fat diet.
    Morgan SA; O'Dea K; Sinclair AJ
    J Am Diet Assoc; 1997 Feb; 97(2):151-6. PubMed ID: 9020242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination.
    Yeshurun D; Abukarshin R; Elias N; Lanir A; Naschitz JE
    Clin Ther; 1993; 15(2):355-63. PubMed ID: 8519043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR
    Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin treatment of hyperlipidemia in kidney transplant recipients on cyclosporine immunosuppression.
    Kandus A; Kovac D; Koselj M; Kveder R; Bren AF
    Transplant Proc; 1994 Oct; 26(5):2642-3. PubMed ID: 7940824
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
    Kłosiewicz-Latoszek L; Nowicka G; Szostak WB
    Wiad Lek; 1993 Aug; 46(15-16):581-5. PubMed ID: 7975581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic use of lovastatin in the treatment of hypercholesterolemia.
    Illingworth DR
    Clin Ther; 1994; 16(1):2-26; discussion 1. PubMed ID: 8205598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia.
    Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT
    Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.